Evidence map›Paper›PMID 30733073›Full record

ArticleThe Journal of arthroplasty2019

Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy.

Susan M Goodman, Allina A Nocon, Nicolas A Selemon, Bo Shopsin, Yi Fulmer, Mary E Decker, Sarah E Grond, Laura T Donlin, Mark P Figgie, Thomas P Sculco and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of arthroplasty, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. What's New in Musculoskeletal Infection.The Journal of bone and joint surgery. American volume · 2020
    Article
  10. Review
  11. International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Susan M GoodmanDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Allina A NoconDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Nicolas A SelemonDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Bo ShopsinDivision of Infectious Diseases, Department of Medicine, NYU School of Medicine, New York, NY.
Yi FulmerDivision of Infectious Diseases, Department of Medicine, NYU School of Medicine, New York, NY.
Mary E DeckerDivision of Infectious Diseases, Department of Medicine, NYU School of Medicine, New York, NY.
Sarah E GrondDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Laura T DonlinDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Mark P FiggieDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Thomas P SculcoDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Linda A RussellDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Michael E HenryDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Anne R BassDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Andy O MillerDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Peter K SculcoDepartment of Medicine, Hospital for Special Surgery, Weill-Cornell Medical School, New York, NY.
Hospital for Special Surgery · USNew York University · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Role of precipitous virulence in invasiveness of community-acquired methicillin-rR01AI103268 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, TORRES, VICTOR J. · 2013 to 2017
$2.1M
NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1 TR002384NIAID NIH HHS HHSN272201400019CNIAID NIH HHS R01 AI103268
6 · The paper itself

Abstract

backgroundRheumatoid arthritis patients are at increased risk for periprosthetic joint infection after arthroplasty. The reason is multifactorial. Nasal colonization with Staphylococcus aureus is a modifiable risk factor; carriage rates in RA patients are unknown. The goal of this study is to determine the S aureus nasal carriage rates of RA patients on biologics, RA patients on traditional disease-modifying anti-rheumatic drugs (DMARDs), and osteoarthritis.

methodsConsecutive patients with RA on biologics (±DMARDs), RA on non-biologic DMARDs, or OA were prospectively enrolled from April 2017 to May 2018. One hundred twenty-three patients were determined necessary per group to show a difference in carriage rates. Patients underwent a nasal swab and answered questions to identify additional risk factors. S aureus positive swabs were further categorized using spa typing. Logistic regression evaluated the association with S aureus colonization between the groups after controlling for known risk factors.

resultsRA patients on biologics, 70% of whom were on DMARDs, had statistically significant increase in S aureus colonization (37%) compared to RA on DMARDs alone (24%), or OA (20%) (P = .01 overall). After controlling for glucocorticoids, antibiotic use, recent hospitalization, and diabetes, RA on biologics had a significant increased risk of S aureus nasal colonization (Odds ratio 1.80, 95% confidence interval 1.00-3.22, P = .047).

conclusionS aureus colonization risk was increased for RA on biologics compared to RA not on biologics and OA. Nasal S aureus carriage increases the risk of surgical site infection; this modifiable risk factor should be addressed prior to total joint arthroplasty for this higher risk patient group.

Indexed as

AgedAnti-Bacterial AgentsAntirheumatic AgentsArthritis, RheumatoidBiological ProductsBiological TherapyCarrier StateDiagnostic Tests, RoutineFemaleHumansMaleMiddle AgedOsteoarthritisRisk FactorsStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsAntirheumatic AgentsBiological Productsbiologicsosteoarthritisperiprosthetic joint infectionrheumatoid arthritisStaphylococcus aureus colonizationtumor necrosis factor inhibitors

Identifiers

PMID30733073
PMCPMC6478534
OpenAlexW2908966388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.